EA201790017A1 - Новая минеральная композиция - Google Patents

Новая минеральная композиция

Info

Publication number
EA201790017A1
EA201790017A1 EA201790017A EA201790017A EA201790017A1 EA 201790017 A1 EA201790017 A1 EA 201790017A1 EA 201790017 A EA201790017 A EA 201790017A EA 201790017 A EA201790017 A EA 201790017A EA 201790017 A1 EA201790017 A1 EA 201790017A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mineral composition
new mineral
relates
present
therapy
Prior art date
Application number
EA201790017A
Other languages
English (en)
Inventor
Эдуард Антониус Йоаннес Арнольдуссен
Original Assignee
Дедраф Холдинг Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дедраф Холдинг Б.В. filed Critical Дедраф Холдинг Б.В.
Publication of EA201790017A1 publication Critical patent/EA201790017A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к области терапии и предотвращения ментальных расстройств, в частности лечению депрессии, эмоционального выгорания и когнитивных расстройств. Конкретнее, настоящее изобретение относится к новой минеральной композиции, содержащей глицинат магния, глицинат цинка и селенометионин, возможно, в сочетании с пиколинатом хрома, таурином и/или витамином В6, подходящей для указанной терапии.
EA201790017A 2014-06-24 2015-06-24 Новая минеральная композиция EA201790017A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2013055 2014-06-24
PCT/NL2015/050460 WO2015199537A1 (en) 2014-06-24 2015-06-24 New mineral composition

Publications (1)

Publication Number Publication Date
EA201790017A1 true EA201790017A1 (ru) 2017-06-30

Family

ID=52014299

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790017A EA201790017A1 (ru) 2014-06-24 2015-06-24 Новая минеральная композиция

Country Status (3)

Country Link
EP (1) EP3160459A1 (ru)
EA (1) EA201790017A1 (ru)
WO (1) WO2015199537A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1025644B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement d'une maladie ou d'un trouble du systeme nerveux central chez un sujet en stimulant et/ou en restaurant la plasticite neuronale

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206895A1 (en) * 1998-11-13 2003-11-06 Sigma-Tau Healthscience S.P.A. Antioxidant composition comprising propionyl L-carnitine and a flavonoid against throm-bosis and atherosclerosis
EP1163904B1 (en) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium
UA77660C2 (en) * 2000-10-03 2007-01-15 Compositions and methods for reducing plasma lipoprotein a level in human
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US7034012B2 (en) * 2002-11-01 2006-04-25 Matthias Rath Composition and method for prevention and treatment of arrhythmias
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
US20110213219A1 (en) * 2010-01-26 2011-09-01 Ridge Diagnostics, Inc. Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression
NL2010214C2 (en) * 2013-01-31 2014-08-04 Brainlabs B V Novel diagnostic method for diagnosing depression and monitoring therapy effectiveness.

Also Published As

Publication number Publication date
EP3160459A1 (en) 2017-05-03
WO2015199537A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
EA201790737A1 (ru) Комбинированная терапия
CR20140020A (es) Compuestos inhibidores de metaloenzimas
EA201790575A1 (ru) Триазолопиразиноны в качестве ингибиторов pde1
CU20140082A7 (es) Pirimidinas y triazinas fusionadas sustituidas y sus uso
MX2018008105A (es) Compuestos inhibidores de metaloenzima.
IN2014DN00286A (ru)
IN2014MN00093A (ru)
IN2014DN06792A (ru)
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
EA201692109A1 (ru) Варианты антител к фактору d и их применение
IN2014MN01378A (ru)
EA201690007A1 (ru) Соединения, ингибирующие металлоферменты
EA201591278A1 (ru) Композиции, содержащие c1-inh, и способы профилактики и лечения расстройств, ассоциированых с дефицитом ингибитора с1 эстеразы
EA201792157A1 (ru) Имидазопиразиноны в качестве ингибиторов pde1
EA201691314A1 (ru) Терапевтические способы и композиции
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
MX370055B (es) Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.
CY1117620T1 (el) Τριτοκαλινη για χρηση στην αντιμετωπιση της κυστικης ινωσης
MX2015011518A (es) Agentes de enlace de met y usos de los mismos.
UY34575A (es) Composiciones y métodos para el tratamiento de diabetes y/u obesidad
EA201691108A1 (ru) Хиназолин-thf-амины в качестве ингибиторов pde1
TW201613628A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
MX2016003293A (es) Metodos y composiciones para el tratamiento de una infeccion por clamidia y enfermedades y trastornos relacionados.
EA201791819A1 (ru) Комбинированная терапия с применением конъюгата антитела против cd19 с лекарственным средством и винкристина
MX2017004723A (es) Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.